title: Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
abstract: Adult sarcomas are highly aggressive tumors that are characterized by high levels of matrix metalloproteinase (MMP)-2 and -9 secretions that degrade the ECM and basement membrane, allowing cancer cells to spread to distal organs. Proteases play a key role in tumor cell invasion and metastasis by digesting the basement membrane and ECM components. Strong clinical and experimental evidence demonstrates association of elevated levels of u-PA and MMPs with cancer progression, metastasis and shortened patient survival. MMP activities are regulated by specific tissue inhibitors of metalloproteinases (TIMPs). Our main objective was to study the effect of a nutrient mixture (NM) on the activity of u-PA, MMPs and TIMPs in various human adult sarcomas. Human fibrosarcoma (HT-1080), chondrosarcoma (SW-1353), liposarcoma (SW-872), synovial sarcoma (SW-982) and uterine leimyosarcoma (SK-UT-1) cell lines (ATCC) were cultured in their respective media and treated at confluence with NM at 0, 50, 100, 250, 500 and 1,000 µg/ml. Analysis of u-PA activity was carried out by fibrin zymography, MMPs by gelatinase zymography and TIMPs by reverse zymography. Fibrosarcoma, chondrosarcoma, liposarcoma and leiomyosarcoma cancer cell lines expressed u-PA, which was inhibited by NM in a dose-dependent manner. However, no bands corresponding to u-PA were detected for synovial sarcoma cells. On gelatinase zymography, fibrosarcoma, chondrosarcoma, liposarcoma and synovial sarcoma showed bands corresponding to MMP-2 and MMP-9 with enhancement of MMP-9 with PMA (100 ng/ml) treatment. Uterine leiomyosarcoma showed strong bands corresponding to inactive and active MMP-9 and a faint band corresponding to MMP-9 dimer induced with PMA treatment, but no MMP-2 band. NM inhibited their expression in a dose-dependent manner. Activity of TIMPs was upregulated by NM in all cancer cell lines in a dose-dependent manner. Analysis revealed a positive correlation between u-PA and MMPs and a negative correlation between u-PA/MMPs and TIMPs. These findings suggest the therapeutic potential of NM in treatment of adult sarcomas.
authors: Dr Rath Research Institute, Santa Clara, CA 95050, USA.
authors: M Waheed
authors: MW
authors: Roomi
authors: Tatiana
authors: T
authors: Kalinovsky
authors: Aleksandra
authors: A
authors: Niedzwiecki
authors: Matthias
authors: M
authors: Rath
mesh_terms: D045744:Cell Line, Tumor; D005109:Extracellular Matrix / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis*; D061965:Matrix Metalloproteinase Inhibitors / Q000378:metabolism; D012509:Sarcoma / Q000145:classification / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000096:biosynthesis*; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis*
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; C560823:TIMP2 protein, human; D019716:Tissue Inhibitor of Metalloproteinase-2; D014568:Urokinase-Type Plasminogen Activator; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
references: Int J Biol Markers. 1999 Oct-Dec;14(4):268-71
references: 10669958
references: Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
references: 12516034
references: Annu Rev Med. 1997;48:489-509
references: 9046979
references: Cancer Metastasis Rev. 1990 Dec;9(4):289-303
references: 1965794
references: Anticancer Res. 1998 Jul-Aug;18(4A):2487-93
references: 9703897
references: J Natl Cancer Inst. 1997 Sep 3;89(17):1260-70
references: 9293916
references: J Urol. 2003 Sep;170(3):773-6
references: 12913695
references: Dig Dis Sci. 2003 Jan;48(1):230-7
references: 12645815
references: Clin Orthop Relat Res. 2000 Apr;(373):88-103
references: 10810466
references: Surg Oncol Clin N Am. 2001 Apr;10(2):383-92, x
references: 11382593
references: Lab Invest. 1983 Aug;49(2):140-7
references: 6348406
references: Oncol Rep. 2010 Sep;24(3):747-57
references: 20664983
references: Nature. 1980 Mar 6;284(5751):67-8
references: 6243750
references: Anticancer Res. 2001 Jan-Feb;21(1A):213-9
references: 11299737
references: Cancer Metastasis Rev. 2010 Sep;29(3):529-42
references: 20717705
references: Am J Clin Pathol. 2005 Mar;123(3):405-14
references: 15716237
references: Cancer Lett. 1996 Jun 5;103(2):183-9
references: 8635156
references: Ann Oncol. 2001 Jan;12(1):75-80
references: 11249053
references: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9
references: 16157892
references: Med Oncol. 2006;23(1):105-11
references: 16645235
references: Prostate. 1997 Aug 1;32(3):188-95
references: 9254898
references: Nutr Hosp. 1995 Nov-Dec;10(6):368-72
references: 8599623
references: Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51
references: 10357558
references: Br J Cancer. 1982 Sep;46(3):354-67
references: 7126425
references: Exp Oncol. 2010 Dec;32(4):243-8
references: 21270751
references: Anticancer Drugs. 1996 Jun;7(4):461-8
references: 8826614
references: J Clin Oncol. 2000 Mar;18(5):1135-49
references: 10694567
references: Am J Clin Nutr. 2000 Jun;71(6 Suppl):1698S-702S; discussion 1703S-4S
references: 10837321
references: Adv Cancer Res. 1985;44:139-266
references: 2930999
references: Int J Cancer. 1997 Jul 3;72(1):1-22
references: 9212216
references: FASEB J. 1990 Apr 1;4(6):1577-90
references: 2180767
references: Br J Cancer. 2010 Feb 16;102(4):731-7
references: 20051950
references: Nat Rev Cancer. 2002 Mar;2(3):161-74
references: 11990853
references: Biochim Biophys Acta. 2002 Apr 29;1596(2):182-92
references: 12007600
references: Clin Chem. 1998 Jun;44(6 Pt 1):1177-83
references: 9625040
references: Histol Histopathol. 2003 Oct;18(4):1035-40
references: 12973672
references: Int J Urol. 2003 Mar;10(3):160-6
references: 12622713
references: J Biol Chem. 2001 Jun 8;276(23):20085-92
references: 11274215
references: Cancer Lett. 1992 Jul 31;65(1):51-4
references: 1511409
references: Carcinogenesis. 1998 Apr;19(4):611-6
references: 9600345
references: J Clin Oncol. 2009 Jun 1;27(16):2712-25
references: 19414669